Liver Fibrosis IL Inhibitors Market Gains Momentum with Breakthrough Drug D...

The global liver fibrosis interleukin (Il) inhibitors market was valued at USD 776.62 million in 2024 and is expected to reach USD 1738.80 million by 2032

• sia7725